Lorenzi M, Ferro A, Cecere F, Scattolin D, et al. First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study. Oncologist 2021 Aug 23. doi: 10.1002/onco.13951.
PMID: 34424565